| Literature DB >> 31034202 |
Zhimin Wang1, Xu Zhen2, Paul Kumar Upputuri2, Yuyan Jiang2, Junwei Lau1, Manojit Pramanik2, Kanyi Pu2, Bengang Xing1.
Abstract
Tumor phototheranostics in the second near-infrared window (NIR-II, 1000-1700 nm) holds great promise due to high spatiotemporal precision, enhanced penetration depth, and therapeutic efficacy. However, current "always-on" NIR-II phototheranostic agents remain restricted by the inherent nonspecificity from the pseudosignal readout and undesirable treatment-related side effects. To address these challenges, herein we explore an activatable and biocompatible nanotheranostics that generates diagnostic and therapeutic effects only after specific activation and enhancement by tumor microenvironmental redox and acid while keeping silent at normal tissues. Such an intelligent "turn-on" chromogenic nanotheranostics allows in vivo nearly zero-background photoacoustic tomography (PAT) and combined effective photothermal tumor therapy (PTT) both in the NIR-II range with minimal adverse effects. In light of the high sensitivity, superior penetration depth, and biocompatibility, this stimuli-activatable NIR-II photo-nanotheranostics provides broad prospects for the investigation and intervention of deep-tissue redox and acid-associated physiological and pathological events.Entities:
Keywords: activatable nanotheranostics; photoacoustic tomography; photothermotherapy; second near-infrared window; tumor microenvironment
Year: 2019 PMID: 31034202 DOI: 10.1021/acsnano.9b01411
Source DB: PubMed Journal: ACS Nano ISSN: 1936-0851 Impact factor: 15.881